Goodrx Enterprise Value Over E B I T D A from 2010 to 2024
| GDRX Stock | USD 4.84 0.02 0.41% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 24.68727441 | Current Value 23.45 | Quarterly Volatility 312.59189268 |
Check Goodrx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Goodrx Holdings' main balance sheet or income statement drivers, such as Interest Income of 30.6 M, Depreciation And Amortization of 113.1 M or Interest Expense of 39.3 M, as well as many indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0599 or PTB Ratio of 3.43. Goodrx financial statements analysis is a perfect complement when working with Goodrx Holdings Valuation or Volatility modules.
Goodrx | Enterprise Value Over E B I T D A |
Latest Goodrx Holdings' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Goodrx Holdings over the last few years. It is Goodrx Holdings' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Goodrx Holdings' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Goodrx Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 389.32 | |
| Coefficient Of Variation | 80.29 | |
| Mean Deviation | 285.98 | |
| Median | 329.60 | |
| Standard Deviation | 312.59 | |
| Sample Variance | 97,714 | |
| Range | 756 | |
| R-Value | (0.90) | |
| Mean Square Error | 19,668 | |
| R-Squared | 0.81 | |
| Slope | (63.03) | |
| Total Sum of Squares | 1.4M |
Goodrx Enterprise Value Over E B I T D A History
About Goodrx Holdings Financial Statements
Goodrx Holdings investors use historical fundamental indicators, such as Goodrx Holdings' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Goodrx Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 24.69 | 23.45 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.